BIIB vs ORLY · P/E 21, rev $9.89B vs P/E 34, rev $17.78B
Biogen Inc (BIIB) versus O’Reilly Automotive Inc (ORLY) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported ORLY revenue for 2025-12-31 was $17.78B. Net income was $2.54B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Not investment advice. Open the BIIB and ORLY stock pages for the full models.
Not investment advice.